Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic

This article explores how artificial intelligence and digital twin technology can significantly revolutionize multiple myeloma patient management. AI integrates complex multimodal data to refine risk stratification, while digital twins provide virtual patient replicas to simulate treatment responses in real-time. Although technical and regulatory challenges remain, these tools aim to deliver personalized, adaptive therapy and improve outcomes.